Questex’s Patients as Partners® in Clinical Research Unveils Conference Program, Thought Leaders from Lurie Children's Hospital, Roche Canada and Tufts University School of Medicine to Keynote
Patients as Partners® in Clinical Research Now Part of Questex’s Fierce Life Sciences Portfolio; First Conference to Put Patients at the Same Level as R&D Executives in a National Event Takes Place in March in Boston
NEW YORK, Dec. 10, 2025 (GLOBE NEWSWIRE) -- Today, Questex’s Patients as Partners® in Clinical Research, the first conference to put patients at the same level as R&D executives in a national event, announces the keynotes and topics for its 13th annual edition. Patients as Partners® in Clinical Research Meeting will take place March 24-26, 2026 at the Renaissance Boston Seaport Hotel in Boston, MA.
Previously organized by the Conference Forum, Patients as Partners in Clinical Research is now part of Questex’s Fierce Life Sciences, where its combined resources offer greater market reach to an event that brings together its largest R&D patient engagement community to navigate the challenges of advancing medicine development for the benefit of patients.
“Joining Questex Fierce Life Sciences brings an expanded database, more outreach, and more resources to support networking and building a larger community to make 2026 the most dynamic conference yet,” said Kate Woda, Senior Director, Patients as Partners® in Clinical Research.
The 2026 keynotes:
Pediatric Trial Experience Keynote with Inaaya Shariq, Lived-Experience Expert & iCan Illinois KIDS Member (Lurie Children's Hospital)
Operationalizing PatientInsights Keynote with Lisa Petermann, Chief Patient Experience Officer, Roche Canada
Optimizing Protocol Data Keynote with Kenneth Getz, MBA, Executive Director & Professor, Tufts CSDD, Tufts University School of Medicine
The 2026 co-chair leadership, representing pharma, patients, and solution providers:
Victoria DiBiaso, VP, Global Head, Patient-Informed Development, Health Value Translation, Sanofi
Gonzalo Linares, Global Head, Patient Advocacy, R&D, J&J Innovative Medicine
Mackenzie Abramson, MPH, Patient Advocate
Sarah Woods, Lived-Experience Expert & Founder, Serenely Guided Foundation
Stacy Hurt, MBA, Chief Patient Officer, Parexel
"The future of patient-centric medicine happens when pharma, patients, and solution partners sit at the same table. When science, strategy, and lived experience come together, we stop guessing what patients need and start building what actually changes lives,” said Mackenzie Abramson, 2026 co-chair and patient advocate.
This year’s meeting brings together more than 20 pharma R&D case studies, over seven hours of dedicated networking, and firsthand patient and regulatory insights, to provide attendees with useful information and strategies to improve clinical trials and medicine development for patients.
The 2026 conference topics:
- Inclusive Representation in Trials
- Patient Engagement Impact Measures
- AI and Digital Tech
- Patient Experience Data/Data Return
- Operationalizing & Scaling Patient Engagement
- Early Patient Engagement
- FDA & Regulatory Updates
- Flexible & Hybrid Trials
- Clinical Trial Site Engagement
- And more
To learn more about Patients as Partners, the full agenda and to register, visit patientsaspartnersconference.com.
Stay connected to Patients As Partners on LinkedIn and follow #PatientsAsPartners2026.
About Patients as Partners
Patients as Partners is co-produced with patients, industry, academia, government and nonprofit organizations to establish a well-rounded program that addresses the needs of all stakeholders seeking to implement and advance patient involvement, access and diversity across the entire clinical development continuum.
About Questex
Questex fuels exceptional business connections—where every buyer and seller interaction matters. Through live events enriched with data insights and active year-round digital communities, we deliver measurable results. It happens here.
Media Contact
BreAnna Bugbee Barrett
Patients as Partners
bbugbee@questex.com
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
